PRTA (PRTA) Stock Price & Analysis
PRTA (PRTA) rose 2.29% to USD 9.82 as of September 8, 2026 at 05:43 UTC, according to Nexqual real-time market data.
PRTA last closed at USD 9.82; the session ranged USD 9.48–9.87 on volume of 383,928 shares. Market capitalization is —, with a 52-week range of USD 7.73–11.8 (NMS). Source: Nexqual, September 8, 2026 at 05:43 UTC.
Key Statistics (as of September 8, 2026 at 05:43 UTC)
| Price | USD 9.82 |
|---|---|
| Change | ▲ 2.29% (up) |
| Previous Close | USD 9.82 |
| Open | USD 9.82 |
| Day Range | USD 9.48 – 9.87 |
| 52-Week Range | USD 7.73 – 11.8 |
| Volume | 383,928 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (PRTA)
Nexqual's technical model rates PRTA "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 05:43 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 63.71 (neutral) |
| vs SMA50 | Above (USD 9.07) |
| MACD | 0.21 (positive) |
From PRTA's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PTCT | PTC Therapeutics, Inc. | USD 69.3 | ▼ 3.47% |
| RARE | Ultragenyx Pharmaceutical Inc. | USD 15.3 | ▼ 42.33% |
| AGIO | Agios Pharmaceuticals, Inc. | USD 33.1 | ▼ 3.02% |
| ENTA | Enanta Pharmaceuticals, Inc. | USD 14.08 | ▼ 0.07% |
| XNCR | Xencor, Inc. | USD 26.61 | ▼ 1.08% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:43 UTC. This page is informational and not investment advice.